Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Oman Healthcare News.
Press releases published on July 16, 2025
Windtree To Launch BNB Crypto Treasury Strategy With Agreement For $60 Million Investment Led By Build And Build Corp. With Up To $140 Million More In Follow On Subscriptions
WARRINGTON, Pa., July 16, 2025 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (“Windtree” or the “Company”) (NasdaqCM: WINT) is excited to announce it has entered into a $60 million securities purchase agreement led by Build and Build Corp, with the …
OKYO Pharma Unveils Strong Phase 2 Clinical Trial Results for Urcosimod to Treat Neuropathic Corneal Pain
After 12 weeks of treatment, 75% of per-protocol patients receiving 0.05% urcosimod showed greater than 80% reduction in neuropathic corneal pain (NCP), as measured by Visual Analogue Scale (VAS), demonstrating highly effective treatment. Urcosimod (0.05%) …
Intuitive demonstrates telesurgery capabilities
SUNNYVALE, Calif., July 16, 2025 (GLOBE NEWSWIRE) -- Intuitive (NASDAQ:ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, has today demonstrated its telesurgery capabilities by remotely connecting two …
Gain Therapeutics Announces Pricing of $7.0 Million Public Offering
BETHESDA, Md., July 16, 2025 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology company leading the discovery and development of the next generation of allosteric small molecule therapies, …
Lattimore Physical Therapy & Sports Rehabilitation Network Rolls Out Athelas Air to 35 Locations
MOUNTAIN VIEW, Calif., July 16, 2025 (GLOBE NEWSWIRE) -- Athelas, healthcare technology company powered by Commure, today announced the successful deployment of its unified EHR platform, Athelas Air, at Lattimore Physical Therapy …
Ensemble Announces Strategic Revenue Cycle Partnership with Methodist Le Bonheur Healthcare
CINCINNATI, Ohio, July 16, 2025 (GLOBE NEWSWIRE) -- Ensemble, the nation’s leading revenue cycle managed services partner for healthcare organizations, announced today that Methodist Le Bonheur Healthcare (MLH) has selected it as its strategic revenue …
Following Psychedelic Science 2025 Success, MAPS Publishes First of Hundreds of Conference Session Videos
Enhanced Virtual Trip platform goes live with improved user experience and first selection of PS2025 session videos Conference drew 8,000+ attendees, more than $1 million donated, and 1,100+ recurring donors joined the new membership program MAPS …
CYCLACEL PHARMACEUTICALS COMMENTS ON RECENT STOCK PRICE VOLATILITY
Kuala Lumpur, Malaysia, July 16, 2025 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; “Cyclacel” or the “Company”), a biopharmaceutical company developing innovative medicines, today commented on recent stock price …
DIAGNOS Files FDA Pre-Submission for its CARA System: Strategic Entry into the U.S. Optometry Market with Support from ORA LLC
BROSSARD, Quebec, July 16, 2025 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a Canadian leader in artificial intelligence (AI) for the early detection of retinal and systemic diseases, is …
DIAGNOS dépose une pré-soumission auprès de la FDA pour son système CARA : Entrée stratégique sur le marché américain de l'optométrie avec le soutien d'ORA LLC
BROSSARD, Québec, 16 juill. 2025 (GLOBE NEWSWIRE) -- Diagnos inc. (« DIAGNOS » ou la « Société ») (Bourse de croissance TSX : ADK, OTCQB : DGNOF, FWB : 4D4A), un leader canadien de l'intelligence artificielle (IA) pour la détection précoce des maladies …
BioAdaptives Announces National Launch of NeuroRush™ — A Cutting-Edge Adaptogenic Nootropic for Mental Clarity, Focus, and Resilience
LAS VEGAS, July 16, 2025 (GLOBE NEWSWIRE) -- BioAdaptives, Inc. (OTC: BDPT), an innovator in evidence-based wellness solutions, today announced the upcoming national release of NeuroRush™, a next-generation nootropic designed to support sustained cognitive …
Silo Pharma Announces Completion of Dosing in Safety Study of PTSD Drug SPC-15
SARASOTA, FL, July 16, 2025 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or the “Company”), a developmental stage biopharmaceutical company focused on novel therapeutics and drug delivery systems, today announced completion of dosing in a U …
SeaStar Medical Grows Customer Base and Expands QUELIMMUNE Surveillance Registry
Highest Rated Children’s Medical Centers Now Employ QUELIMMUNE for Ultra-Rare Cases of Pediatric AKI HDE Surveillance Registry Data Captures Key Metrics for Future Analysis of QUELIMMUNE Performance DENVER, July 16, 2025 (GLOBE NEWSWIRE) -- SeaStar Medical …
Henry Ford Health Initiates Patient Enrollment for BioCardia’s CardiAMP HF II Pivotal Study for Ischemic Heart Failure of Reduced Ejection Fraction
SUNNYVALE, Calif., July 16, 2025 (GLOBE NEWSWIRE) -- BioCardia, Inc. [Nasdaq: BCDA], a global leader in cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, announced today that Henry Ford Health in Detroit, …
Silexion Therapeutics Announces 1-for-15 Reverse Share Split
Grand Cayman, Cayman Islands, July 16, 2025 (GLOBE NEWSWIRE) -- Silexion Therapeutics Corp. (NASDAQ: SLXN) (“Silexion” or the “Company”), a clinical-stage biotechnology company pioneering RNA interference (RNAi) therapies for KRAS-driven cancers, today …
Oragenics, Inc. Announces U.S.-Based Drug Manufacturing Agreement to Support ONP-002 Clinical Development
SARASOTA, Fla., July 16, 2025 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN), a biotechnology company developing intranasal therapeutics for brain-related conditions, today announced it has entered into a manufacturing agreement with Sterling …
Intelligent Bio Solutions Accelerates Global Growth with SmarTest® Patch Agreement, Reinforces U.S. Expansion Path as FDA Approval Remains a Strategic Priority
NEW YORK, July 16, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced a new global distribution …
Adial Pharmaceuticals Regains Compliance with Nasdaq Stockholders’ Equity Listing Requirement
GLEN ALLEN, Va., July 16, 2025 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and related …
TOMI Environmental Solutions Advances New Product, SteraMist Integration System – Standalone (SIS-SA)
FREDERICK, Md., July 16, 2025 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ: TOMZ), a global company specializing in disinfection and decontamination solutions, today announced the successful first installation of its new …
Vystar Launches New Website and Unveils Brand Refresh www.vytex.com
Boston, MA, July 16, 2025 (GLOBE NEWSWIRE) -- Vystar® Corporation (OTCQB: VYST) Vytex manufacturer Vystar has today launched a newly-redesigned website www.vytex.com to work alongside the new brand refresh and overall digital strategy. The completely …